Purpose The exact effect of vitamin D supplementation, either as monotherapy or in
combination with protein, on musculoskeletal health in patients with sarcopenia is currently …

Significant progress in our understanding of cancer cachexia has occurred in recent years.
Despite these advances, no pharmacologic agent has achieved US Food and Drug …

Rationale Cancer is associated with muscle wasting. However, optimal protein intake has
not been determined, limiting the efficacy of nutritional interventions. This systematic review …

Paraneoplastic conditions such as cancer cachexia are often exacerbated by chemotherapy,
which affects the patient's quality of life as well as the response to therapy. The aim of this …

Doxorubicin (Doxo) is a widely used antineoplastic drug with limited clinical application due
to its deleterious dose-related side effects. We investigated whether nicotinamide …

Up to 70% of people with lung cancer may be affected by cancer-related malnutrition or
muscle loss, depending on treatment modality and disease stage. This narrative review …

Background Computed tomography images acquired during routine cancer care provide an
opportunity to determine body composition with accuracy and precision. Quantification of …

Background In older adults, skeletal muscle mass is an important factor for health and
prognosis. The loss of SMM during neoadjuvant therapy affects the prognosis of patients …

Background Low-skeletal muscle mass (LSMM) is defined as progressive skeletal muscle
loss, which can be assessed by imaging modalities. It was shown that this parameter is …

The adverse side effect of cancer therapy on skeletal muscle has been largely ignored in the
development of cancer therapeutics. Given the extent to which loss of muscle mass and …